Cargando…
Isolating and targeting the real-time plasticity and malignant properties of epithelial-mesenchymal transition in cancer
Epithelial-mesenchymal transition (EMT) is a driving force in promoting malignant cancer, including initiation, growth, and metastasis. EMT is a dynamic process that can undergo a mesenchymal-epithelial transition (MET) and partial transitions between both phenotypes, termed epithelial-mesenchymal p...
Autores principales: | Esquer, Hector, Zhou, Qiong, Nemkov, Travis, Abraham, Adedoyin D., Rinaldetti, Sébastien, Chen, Yu-Chi, Zhang, Xiaohu, Orman, Michael V., D’Alessandro, Angelo, Ferrer, Marc, Messersmith, Wells A., LaBarbera, Daniel V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944243/ https://www.ncbi.nlm.nih.gov/pubmed/33742123 http://dx.doi.org/10.1038/s41388-021-01728-2 |
Ejemplares similares
-
High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes
por: Rinaldetti, Sébastien, et al.
Publicado: (2022) -
An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent
por: Li, Linfeng, et al.
Publicado: (2014) -
AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer
por: Agarwal, Neeraj, et al.
Publicado: (2022) -
Topoisomerase IIα mediates TCF-dependent epithelial–mesenchymal transition in colon cancer
por: Zhou, Q, et al.
Publicado: (2016) -
High-Throughput Metabolomics Platform for the Rapid Data-Driven Development of Novel Additive Solutions for Blood Storage
por: Nemkov, Travis, et al.
Publicado: (2022)